nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoteridol—Tearing eyes—Docetaxel—melanoma	0.0605	0.0605	CcSEcCtD
Gadoteridol—Rash maculo-papular—Vemurafenib—melanoma	0.0266	0.0266	CcSEcCtD
Gadoteridol—Stupor—Carmustine—melanoma	0.0207	0.0207	CcSEcCtD
Gadoteridol—Injection site pain—Carmustine—melanoma	0.0189	0.0189	CcSEcCtD
Gadoteridol—Wheezing—Bleomycin—melanoma	0.0172	0.0172	CcSEcCtD
Gadoteridol—Injection site reaction—Carmustine—melanoma	0.0154	0.0154	CcSEcCtD
Gadoteridol—Depressed level of consciousness—Carmustine—melanoma	0.0149	0.0149	CcSEcCtD
Gadoteridol—Urinary incontinence—Carmustine—melanoma	0.0149	0.0149	CcSEcCtD
Gadoteridol—Urinary incontinence—Temozolomide—melanoma	0.0144	0.0144	CcSEcCtD
Gadoteridol—Depressed level of consciousness—Temozolomide—melanoma	0.0144	0.0144	CcSEcCtD
Gadoteridol—Erythema—Vemurafenib—melanoma	0.0128	0.0128	CcSEcCtD
Gadoteridol—Dysgeusia—Vemurafenib—melanoma	0.0125	0.0125	CcSEcCtD
Gadoteridol—Cough—Vemurafenib—melanoma	0.0111	0.0111	CcSEcCtD
Gadoteridol—Face oedema—Carmustine—melanoma	0.0108	0.0108	CcSEcCtD
Gadoteridol—Lacrimation increased—Docetaxel—melanoma	0.0108	0.0108	CcSEcCtD
Gadoteridol—Face oedema—Temozolomide—melanoma	0.0105	0.0105	CcSEcCtD
Gadoteridol—Anaphylactic shock—Vemurafenib—melanoma	0.0104	0.0104	CcSEcCtD
Gadoteridol—Dysphagia—Dactinomycin—melanoma	0.0104	0.0104	CcSEcCtD
Gadoteridol—Injection site reaction—Docetaxel—melanoma	0.00987	0.00987	CcSEcCtD
Gadoteridol—Hypotension—Vemurafenib—melanoma	0.00974	0.00974	CcSEcCtD
Gadoteridol—Dysphagia—Carmustine—melanoma	0.0097	0.0097	CcSEcCtD
Gadoteridol—Fluid retention—Docetaxel—melanoma	0.00943	0.00943	CcSEcCtD
Gadoteridol—Dysphagia—Temozolomide—melanoma	0.00937	0.00937	CcSEcCtD
Gadoteridol—Flushing—Bleomycin—melanoma	0.00825	0.00825	CcSEcCtD
Gadoteridol—Body temperature increased—Vemurafenib—melanoma	0.00824	0.00824	CcSEcCtD
Gadoteridol—Erythema—Bleomycin—melanoma	0.00774	0.00774	CcSEcCtD
Gadoteridol—Flushing—Dactinomycin—melanoma	0.0077	0.0077	CcSEcCtD
Gadoteridol—Hypersensitivity—Vemurafenib—melanoma	0.00768	0.00768	CcSEcCtD
Gadoteridol—Pruritus—Vemurafenib—melanoma	0.00738	0.00738	CcSEcCtD
Gadoteridol—Erythema—Dactinomycin—melanoma	0.00722	0.00722	CcSEcCtD
Gadoteridol—Flushing—Carmustine—melanoma	0.0072	0.0072	CcSEcCtD
Gadoteridol—Ill-defined disorder—Bleomycin—melanoma	0.00718	0.00718	CcSEcCtD
Gadoteridol—Diarrhoea—Vemurafenib—melanoma	0.00713	0.00713	CcSEcCtD
Gadoteridol—Tinnitus—Temozolomide—melanoma	0.00699	0.00699	CcSEcCtD
Gadoteridol—Malaise—Bleomycin—melanoma	0.00698	0.00698	CcSEcCtD
Gadoteridol—Flushing—Temozolomide—melanoma	0.00696	0.00696	CcSEcCtD
Gadoteridol—Dizziness—Vemurafenib—melanoma	0.00689	0.00689	CcSEcCtD
Gadoteridol—Erythema—Carmustine—melanoma	0.00676	0.00676	CcSEcCtD
Gadoteridol—Cough—Bleomycin—melanoma	0.00675	0.00675	CcSEcCtD
Gadoteridol—Ill-defined disorder—Dactinomycin—melanoma	0.0067	0.0067	CcSEcCtD
Gadoteridol—Vomiting—Vemurafenib—melanoma	0.00663	0.00663	CcSEcCtD
Gadoteridol—Chest pain—Bleomycin—melanoma	0.00659	0.00659	CcSEcCtD
Gadoteridol—Rash—Vemurafenib—melanoma	0.00657	0.00657	CcSEcCtD
Gadoteridol—Dermatitis—Vemurafenib—melanoma	0.00657	0.00657	CcSEcCtD
Gadoteridol—Headache—Vemurafenib—melanoma	0.00653	0.00653	CcSEcCtD
Gadoteridol—Erythema—Temozolomide—melanoma	0.00653	0.00653	CcSEcCtD
Gadoteridol—Discomfort—Bleomycin—melanoma	0.00651	0.00651	CcSEcCtD
Gadoteridol—Malaise—Dactinomycin—melanoma	0.00651	0.00651	CcSEcCtD
Gadoteridol—Dysgeusia—Temozolomide—melanoma	0.00639	0.00639	CcSEcCtD
Gadoteridol—Tremor—Carmustine—melanoma	0.00633	0.00633	CcSEcCtD
Gadoteridol—Anaphylactic shock—Bleomycin—melanoma	0.00632	0.00632	CcSEcCtD
Gadoteridol—Oedema—Bleomycin—melanoma	0.00632	0.00632	CcSEcCtD
Gadoteridol—Dysphagia—Docetaxel—melanoma	0.00623	0.00623	CcSEcCtD
Gadoteridol—Nausea—Vemurafenib—melanoma	0.00619	0.00619	CcSEcCtD
Gadoteridol—Tremor—Temozolomide—melanoma	0.00612	0.00612	CcSEcCtD
Gadoteridol—Discomfort—Dactinomycin—melanoma	0.00607	0.00607	CcSEcCtD
Gadoteridol—Ill-defined disorder—Temozolomide—melanoma	0.00606	0.00606	CcSEcCtD
Gadoteridol—Hypotension—Bleomycin—melanoma	0.0059	0.0059	CcSEcCtD
Gadoteridol—Oedema—Dactinomycin—melanoma	0.00589	0.00589	CcSEcCtD
Gadoteridol—Malaise—Temozolomide—melanoma	0.00589	0.00589	CcSEcCtD
Gadoteridol—Convulsion—Carmustine—melanoma	0.00585	0.00585	CcSEcCtD
Gadoteridol—Hypertension—Carmustine—melanoma	0.00583	0.00583	CcSEcCtD
Gadoteridol—Chest pain—Carmustine—melanoma	0.00575	0.00575	CcSEcCtD
Gadoteridol—Anxiety—Carmustine—melanoma	0.00573	0.00573	CcSEcCtD
Gadoteridol—Cough—Temozolomide—melanoma	0.0057	0.0057	CcSEcCtD
Gadoteridol—Paraesthesia—Bleomycin—melanoma	0.00567	0.00567	CcSEcCtD
Gadoteridol—Convulsion—Temozolomide—melanoma	0.00566	0.00566	CcSEcCtD
Gadoteridol—Hypertension—Temozolomide—melanoma	0.00564	0.00564	CcSEcCtD
Gadoteridol—Dyspnoea—Bleomycin—melanoma	0.00563	0.00563	CcSEcCtD
Gadoteridol—Anxiety—Temozolomide—melanoma	0.00554	0.00554	CcSEcCtD
Gadoteridol—Oedema—Carmustine—melanoma	0.00551	0.00551	CcSEcCtD
Gadoteridol—Discomfort—Temozolomide—melanoma	0.00549	0.00549	CcSEcCtD
Gadoteridol—Dry mouth—Temozolomide—melanoma	0.00544	0.00544	CcSEcCtD
Gadoteridol—Pain—Bleomycin—melanoma	0.0054	0.0054	CcSEcCtD
Gadoteridol—Oedema—Temozolomide—melanoma	0.00533	0.00533	CcSEcCtD
Gadoteridol—Anaphylactic shock—Temozolomide—melanoma	0.00533	0.00533	CcSEcCtD
Gadoteridol—Feeling abnormal—Bleomycin—melanoma	0.00521	0.00521	CcSEcCtD
Gadoteridol—Hypotension—Carmustine—melanoma	0.00515	0.00515	CcSEcCtD
Gadoteridol—Hyperhidrosis—Temozolomide—melanoma	0.00515	0.00515	CcSEcCtD
Gadoteridol—Pain—Dactinomycin—melanoma	0.00504	0.00504	CcSEcCtD
Gadoteridol—Urticaria—Bleomycin—melanoma	0.00502	0.00502	CcSEcCtD
Gadoteridol—Rhinitis—Docetaxel—melanoma	0.005	0.005	CcSEcCtD
Gadoteridol—Body temperature increased—Bleomycin—melanoma	0.00499	0.00499	CcSEcCtD
Gadoteridol—Paraesthesia—Carmustine—melanoma	0.00495	0.00495	CcSEcCtD
Gadoteridol—Dyspnoea—Carmustine—melanoma	0.00492	0.00492	CcSEcCtD
Gadoteridol—Feeling abnormal—Dactinomycin—melanoma	0.00485	0.00485	CcSEcCtD
Gadoteridol—Paraesthesia—Temozolomide—melanoma	0.00478	0.00478	CcSEcCtD
Gadoteridol—Dyspnoea—Temozolomide—melanoma	0.00475	0.00475	CcSEcCtD
Gadoteridol—Pain—Carmustine—melanoma	0.00472	0.00472	CcSEcCtD
Gadoteridol—Abdominal pain—Dactinomycin—melanoma	0.00466	0.00466	CcSEcCtD
Gadoteridol—Body temperature increased—Dactinomycin—melanoma	0.00466	0.00466	CcSEcCtD
Gadoteridol—Hypersensitivity—Bleomycin—melanoma	0.00465	0.00465	CcSEcCtD
Gadoteridol—Flushing—Docetaxel—melanoma	0.00463	0.00463	CcSEcCtD
Gadoteridol—Pain—Temozolomide—melanoma	0.00456	0.00456	CcSEcCtD
Gadoteridol—Feeling abnormal—Carmustine—melanoma	0.00454	0.00454	CcSEcCtD
Gadoteridol—Pruritus—Bleomycin—melanoma	0.00447	0.00447	CcSEcCtD
Gadoteridol—Feeling abnormal—Temozolomide—melanoma	0.00439	0.00439	CcSEcCtD
Gadoteridol—Abdominal pain—Carmustine—melanoma	0.00436	0.00436	CcSEcCtD
Gadoteridol—Body temperature increased—Carmustine—melanoma	0.00436	0.00436	CcSEcCtD
Gadoteridol—Erythema—Docetaxel—melanoma	0.00434	0.00434	CcSEcCtD
Gadoteridol—Hypersensitivity—Dactinomycin—melanoma	0.00434	0.00434	CcSEcCtD
Gadoteridol—Dysgeusia—Docetaxel—melanoma	0.00425	0.00425	CcSEcCtD
Gadoteridol—Urticaria—Temozolomide—melanoma	0.00423	0.00423	CcSEcCtD
Gadoteridol—Body temperature increased—Temozolomide—melanoma	0.00421	0.00421	CcSEcCtD
Gadoteridol—Abdominal pain—Temozolomide—melanoma	0.00421	0.00421	CcSEcCtD
Gadoteridol—Hypersensitivity—Carmustine—melanoma	0.00406	0.00406	CcSEcCtD
Gadoteridol—Diarrhoea—Dactinomycin—melanoma	0.00403	0.00403	CcSEcCtD
Gadoteridol—Vomiting—Bleomycin—melanoma	0.00402	0.00402	CcSEcCtD
Gadoteridol—Rash—Bleomycin—melanoma	0.00398	0.00398	CcSEcCtD
Gadoteridol—Dermatitis—Bleomycin—melanoma	0.00398	0.00398	CcSEcCtD
Gadoteridol—Hypersensitivity—Temozolomide—melanoma	0.00393	0.00393	CcSEcCtD
Gadoteridol—Syncope—Docetaxel—melanoma	0.00389	0.00389	CcSEcCtD
Gadoteridol—Loss of consciousness—Docetaxel—melanoma	0.00382	0.00382	CcSEcCtD
Gadoteridol—Cough—Docetaxel—melanoma	0.00379	0.00379	CcSEcCtD
Gadoteridol—Diarrhoea—Carmustine—melanoma	0.00377	0.00377	CcSEcCtD
Gadoteridol—Pruritus—Temozolomide—melanoma	0.00377	0.00377	CcSEcCtD
Gadoteridol—Convulsion—Docetaxel—melanoma	0.00376	0.00376	CcSEcCtD
Gadoteridol—Nausea—Bleomycin—melanoma	0.00375	0.00375	CcSEcCtD
Gadoteridol—Hypertension—Docetaxel—melanoma	0.00375	0.00375	CcSEcCtD
Gadoteridol—Vomiting—Dactinomycin—melanoma	0.00375	0.00375	CcSEcCtD
Gadoteridol—Rash—Dactinomycin—melanoma	0.00371	0.00371	CcSEcCtD
Gadoteridol—Chest pain—Docetaxel—melanoma	0.0037	0.0037	CcSEcCtD
Gadoteridol—Dizziness—Carmustine—melanoma	0.00365	0.00365	CcSEcCtD
Gadoteridol—Diarrhoea—Temozolomide—melanoma	0.00365	0.00365	CcSEcCtD
Gadoteridol—Dry mouth—Docetaxel—melanoma	0.00361	0.00361	CcSEcCtD
Gadoteridol—Anaphylactic shock—Docetaxel—melanoma	0.00354	0.00354	CcSEcCtD
Gadoteridol—Oedema—Docetaxel—melanoma	0.00354	0.00354	CcSEcCtD
Gadoteridol—Dizziness—Temozolomide—melanoma	0.00352	0.00352	CcSEcCtD
Gadoteridol—Vomiting—Carmustine—melanoma	0.00351	0.00351	CcSEcCtD
Gadoteridol—Nausea—Dactinomycin—melanoma	0.0035	0.0035	CcSEcCtD
Gadoteridol—Shock—Docetaxel—melanoma	0.00349	0.00349	CcSEcCtD
Gadoteridol—Rash—Carmustine—melanoma	0.00348	0.00348	CcSEcCtD
Gadoteridol—Dermatitis—Carmustine—melanoma	0.00347	0.00347	CcSEcCtD
Gadoteridol—Headache—Carmustine—melanoma	0.00345	0.00345	CcSEcCtD
Gadoteridol—Vomiting—Temozolomide—melanoma	0.00339	0.00339	CcSEcCtD
Gadoteridol—Rash—Temozolomide—melanoma	0.00336	0.00336	CcSEcCtD
Gadoteridol—Dermatitis—Temozolomide—melanoma	0.00336	0.00336	CcSEcCtD
Gadoteridol—Headache—Temozolomide—melanoma	0.00334	0.00334	CcSEcCtD
Gadoteridol—Hypotension—Docetaxel—melanoma	0.00331	0.00331	CcSEcCtD
Gadoteridol—Nausea—Carmustine—melanoma	0.00328	0.00328	CcSEcCtD
Gadoteridol—Paraesthesia—Docetaxel—melanoma	0.00318	0.00318	CcSEcCtD
Gadoteridol—Nausea—Temozolomide—melanoma	0.00316	0.00316	CcSEcCtD
Gadoteridol—Dyspnoea—Docetaxel—melanoma	0.00316	0.00316	CcSEcCtD
Gadoteridol—Pain—Docetaxel—melanoma	0.00303	0.00303	CcSEcCtD
Gadoteridol—Feeling abnormal—Docetaxel—melanoma	0.00292	0.00292	CcSEcCtD
Gadoteridol—Abdominal pain—Docetaxel—melanoma	0.0028	0.0028	CcSEcCtD
Gadoteridol—Body temperature increased—Docetaxel—melanoma	0.0028	0.0028	CcSEcCtD
Gadoteridol—Hypersensitivity—Docetaxel—melanoma	0.00261	0.00261	CcSEcCtD
Gadoteridol—Pruritus—Docetaxel—melanoma	0.00251	0.00251	CcSEcCtD
Gadoteridol—Diarrhoea—Docetaxel—melanoma	0.00242	0.00242	CcSEcCtD
Gadoteridol—Dizziness—Docetaxel—melanoma	0.00234	0.00234	CcSEcCtD
Gadoteridol—Vomiting—Docetaxel—melanoma	0.00225	0.00225	CcSEcCtD
Gadoteridol—Rash—Docetaxel—melanoma	0.00223	0.00223	CcSEcCtD
Gadoteridol—Dermatitis—Docetaxel—melanoma	0.00223	0.00223	CcSEcCtD
Gadoteridol—Headache—Docetaxel—melanoma	0.00222	0.00222	CcSEcCtD
Gadoteridol—Nausea—Docetaxel—melanoma	0.0021	0.0021	CcSEcCtD
